01/17/2025
4:20 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
8:41 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2024
7:30 PM | Kairos Pharma (Issuer)
Murali Ramachandran (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
5:03 AM | Kairos Pharma (Issuer)
Samuelson Doug (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
8:53 PM | Kairos Pharma (Issuer)
Yu John S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
7:48 AM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
1:19 PM | Kairos Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2024
4:30 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2024
4:29 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:10 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:17 PM | Kairos Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
09/24/2024
8:00 PM | Bae Hyun W. (Reporting)
Kairos Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
Yu John S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
Samuelson Doug (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
Keyoung Hansoo Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
Murali Ramachandran (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Kairos Pharma (Issuer)
MAZANET ROSEMARY (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
8:00 PM | Bhowmick Neil (Reporting)
Kairos Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2024
3:22 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
3:15 PM | Kairos Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/17/2024
5:36 AM | Kairos Pharma (Filer)
| Form 424B4 | |
09/16/2024
11:15 PM | Kairos Pharma (Filer)
| Form EFFECT | |
09/12/2024
12:57 PM | Kairos Pharma (Filer)
| Form CERT | |
09/12/2024
11:44 AM | Kairos Pharma (Filer)
| Form 8-A12B | |
08/16/2024
4:30 PM | Kairos Pharma (Filer)
| Form S-1/A | |
06/03/2024
8:13 PM | Kairos Pharma (Filer)
| Form S-1/A | |
05/20/2024
7:07 AM | Kairos Pharma (Filer)
| Form S-1/A | |
05/10/2024
7:14 PM | Kairos Pharma (Filer)
| Form S-1/A | |
04/30/2024
7:43 PM | Kairos Pharma (Filer)
| Form S-1/A | |
02/14/2024
4:27 PM | Kairos Pharma (Filer)
| Form S-1/A | |
